MX2022006018A - Nanoporos artificiales y usos y metodos relacionados con los mismos. - Google Patents

Nanoporos artificiales y usos y metodos relacionados con los mismos.

Info

Publication number
MX2022006018A
MX2022006018A MX2022006018A MX2022006018A MX2022006018A MX 2022006018 A MX2022006018 A MX 2022006018A MX 2022006018 A MX2022006018 A MX 2022006018A MX 2022006018 A MX2022006018 A MX 2022006018A MX 2022006018 A MX2022006018 A MX 2022006018A
Authority
MX
Mexico
Prior art keywords
methods relating
nanopores
subunit
forming protein
artificial
Prior art date
Application number
MX2022006018A
Other languages
English (en)
Inventor
Giovanni Maglia
Shengli Zhang
Original Assignee
Univ Groningen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Groningen filed Critical Univ Groningen
Publication of MX2022006018A publication Critical patent/MX2022006018A/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/48707Physical analysis of biological material of liquid biological material by electrical means
    • G01N33/48721Investigating individual macromolecules, e.g. by translocation through nanopores
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/60Detection means characterised by use of a special device
    • C12Q2565/631Detection means characterised by use of a special device being a biochannel or pore

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La invención se relaciona con el campo de los nanoporos y su uso en el análisis de biopolímeros, incluidos polipéptidos y polinucleótidos. Se proporciona un nanoporo artificial que comprende un conjunto multimérico de subunidades, cada una de las cuales comprende (i) la secuencia transmembrana (TM) de una proteína formadora de poros barril ß o a-helicoidal fusionada con la secuencia de aminoácidos de (ii) una subunidad de una proteína formadora de anillos capaz de controlar el transporte de un polipéptido o polinucleótido a través de la región TM del conjunto.
MX2022006018A 2019-11-19 2020-11-19 Nanoporos artificiales y usos y metodos relacionados con los mismos. MX2022006018A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19210168 2019-11-19
PCT/NL2020/050726 WO2021101378A1 (en) 2019-11-19 2020-11-19 Artificial nanopores and uses and methods relating thereto

Publications (1)

Publication Number Publication Date
MX2022006018A true MX2022006018A (es) 2022-09-12

Family

ID=68840857

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022006018A MX2022006018A (es) 2019-11-19 2020-11-19 Nanoporos artificiales y usos y metodos relacionados con los mismos.

Country Status (11)

Country Link
US (2) US20220412948A1 (es)
EP (1) EP4061965A1 (es)
JP (1) JP2023502658A (es)
KR (1) KR20220100901A (es)
CN (1) CN114981450A (es)
AU (1) AU2020389020A1 (es)
BR (1) BR112022009402A2 (es)
CA (1) CA3161981A1 (es)
IL (1) IL293024A (es)
MX (1) MX2022006018A (es)
WO (1) WO2021101378A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3111488A1 (en) 2018-09-11 2020-03-19 Rijksuniversiteit Groningen Biological nanopores having tunable pore diameters and uses thereof as analytical tools
WO2023225988A1 (zh) * 2022-05-27 2023-11-30 深圳华大生命科学研究院 一种维持纳米孔测序速度的方法
WO2024091124A1 (en) 2022-10-28 2024-05-02 Rijksuniversiteit Groningen Nanopore-based analysis of proteins
WO2024091123A1 (en) 2022-10-28 2024-05-02 Rijksuniversiteit Groningen Nanopore systems and methods for single-molecule polymer profiling
CN117417421B (zh) * 2023-01-12 2024-07-23 北京普译生物科技有限公司 一种突变体膜蛋白复合物纳米孔及其应用
WO2024205413A1 (en) * 2023-03-30 2024-10-03 Rijksuniversiteit Groningen Large conical nanopores and uses thereof in analyte sensing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103695530B (zh) 2008-07-07 2016-05-25 牛津纳米孔技术有限公司 酶-孔构建体
FR3003268B1 (fr) 2013-03-13 2018-01-19 Roquette Freres Bioreacteur
JP7237586B2 (ja) * 2015-12-08 2023-03-13 カトリック ユニヴェルシテット ルーヴェン カーユー ルーヴェン リサーチ アンド ディベロップメント 修飾ナノポア、それを含む組成物およびその使用
EP3423485B1 (en) * 2016-03-02 2021-12-29 Oxford Nanopore Technologies plc Mutant pore
CN109890980A (zh) 2016-07-12 2019-06-14 格罗宁根大学 基于FraC actinoporin的用于生物聚合物传感和测序的生物纳米孔
GB201809323D0 (en) * 2018-06-06 2018-07-25 Oxford Nanopore Tech Ltd Method

Also Published As

Publication number Publication date
KR20220100901A (ko) 2022-07-18
US20220412948A1 (en) 2022-12-29
CA3161981A1 (en) 2021-05-27
CN114981450A (zh) 2022-08-30
JP2023502658A (ja) 2023-01-25
BR112022009402A2 (pt) 2022-08-09
US20240288416A1 (en) 2024-08-29
WO2021101378A1 (en) 2021-05-27
EP4061965A1 (en) 2022-09-28
AU2020389020A1 (en) 2022-06-09
IL293024A (en) 2022-07-01

Similar Documents

Publication Publication Date Title
MX2022006018A (es) Nanoporos artificiales y usos y metodos relacionados con los mismos.
MX2021000047A (es) Proteina de fusion variante pd1-4-1bbl y procedimientos de uso de la misma.
EA201170993A1 (ru) Удлиненные рекомбинантные полипептиды и содержащие их композиции
UA120917C2 (uk) Химерний білок фактора viii та його застосування
HRP20210734T1 (hr) Koštani morfogenetski proteini
JP2019507583A5 (es)
GEP20227447B (en) Constructs having sirp-alpha domain or variant thereof
EA202092362A1 (ru) Вирусные векторы для нацеливания на ткани глаза
MX2021000263A (es) Proteina de fusion variante sirpalfa-4-1bbl y procedimientos de uso de la misma.
MX2020010075A (es) Constructos de polipeptido de lisina-peptido anti-microbiano (amp), lisinas, polinucleotidos aislados que codifican para estas, y sus usos.
PH12021550885A1 (en) Glucagon like peptide 1 (glp1)-growth differentiation factor 15 (gdf15) fusion proteins and uses thereof
DE60330767D1 (de) Ferritinfusionsproteine zur verwendung für impfstoffe und andere anwendungen
ATE472334T1 (de) Polypeptidsequenzen, die an der modulation des immunsupppressiven effekts viraler proteine beteiligt sind
MX2021012047A (es) Polipeptidos de fusion de serpina y metodos para utilizar los mismos.
EA201791238A1 (ru) Способы и композиции, в которых используются варианты полипептидов klotho
MX2020010806A (es) Peptidos anti-inflamatorios y usos de los mismos.
PE20190743A1 (es) Metodos para el tratamiento de la atrofia muscular y enfermedad osea con el uso de proteinas trap hibridas novedosas del ligando actriib
MX2021011726A (es) Escindasas modificadas, usos de las mismas y kits relacionados.
WO2009001260A3 (en) Cosmetic use of apolipoprotein d type proteins
MX2020010199A (es) Polipeptidos antigenicos del virus sincitial respiratorio.
MX2023008351A (es) Heterodimeros de proteinas de membrana tipo i y metodos de uso de los mismos.
EP4374913A3 (en) Novel human serum albumin mutant
RU2017132689A (ru) СЛИТАЯ С Fc α-ЦЕПЬ ВЫСОКОАФФИННОГО РЕЦЕПТОРА IgE
EP3795586A3 (en) Production of proteins in labyrinthulomycetes
WO2019108924A3 (en) Cdkl5 expression variants and cdkl5 fusion proteins